The World Health Organization says Omicron health officials are more concerned about the potential for infection than with the original corona virus strain, which also has a higher number of mutations.

Fauci told CNN on Friday that there was no evidence that the alternative had gone to the United States.

The CDC said the diversified surveillance system in the United States has reliably detected new variations in the past.

“We look forward to recognizing soon if Omigron appears in the United States,” the company said in a statement.

The European Center for Disease Control and Prevention said on Friday that the virus has the “highest to highest” risk of spreading across the continent.

Vaccine makers are working to determine their effectiveness against Omigran

Meanwhile, vaccine makers have revealed that they are taking action to address the increased risk of omigran.

Moderna said Friday that it is rapidly testing its vaccine’s ability to neutralize Omicron, with data expected in the coming weeks.

In a press release, Moderna said, “The strain is believed to improve transmission, and mutations found in beta and delta variants are believed to improve immunity.”

“The combination of mutations poses a significant potential risk of accelerating the erosion of natural and vaccine-induced immunity.”

Moderna has made it clear that the potential solution is to motivate people with a larger dose if the current vaccine and booster replacement are not adequate, which is being tested.

The company is evaluating two polyvalent booster candidates to see if it offers better protection against Omicron – both of which have some virus mutations found in the variant.

Moderna is also testing a specific Omigron booster.

“For several days, we have been moving fast to implement our strategy to address this alternative,” said Stephen Boncel, CEO of Moderna, in a statement.

Scientists at BioNTech, a German company that has partnered with Pfizer to develop the Covid-19 vaccine, are exploring the impact of injection variation, with data expected in the coming weeks.

A Johnson & Johnson spokesman told CNN that the company was testing the effectiveness of the vaccine against Omigran.

Experts say travel restrictions for Govt-19 are not so effective

The decision by the Biden administration to restrict travel to eight countries is a precautionary measure as the US government learns more about the Omigron type corona virus.

But some experts say travel restrictions are not as effective as they appear.

“The travel ban is moderately effective.

“But it’s obviously allowing American citizens to come back. They can bring the virus. And people can go out of the country in question, for example, to South Africa, and other travel-free countries, and come in sideways. So the travel ban would be somewhat effective, but do not expect a miracle.

Excluded from the new restrictions are US citizens, legal permanent residents and non-citizens who are citizens or spouses of permanent residents.

Dr. Megan Rane, professor of emergency medicine at the Brown University and associate dean of public health, said the common vaccine requirements for all flights would be highly effective.

“Or go to isolation when people from other countries come to the United States. Both of those things are not currently politically desirable, but they will make a huge difference in spreading that alternative,” Rane told CNN reporter Jim Agosta on Friday. .